Post-Flushing merger (closed 2026-06-01) + $225M Warburg Pincus injection reshape OCFC into a $23B-asset Northeast franchise trading at 0.88x TBV vs peer median ~1.15x. Hard floor at tangible book ($19.86/sh) anchors downside; ~16% EPS accretion + NIM expansion + multifamily de-risking ($1.4B sale) underwrite mid-cycle re-rating. Asymmetry ratio ≥3x: floor regulatory-anchored, upside path identified, but execution risk on Flushing integration and NYC CRE residuals must be monitored.
Methodology: Implied multiple at base case = 1.13x P/TBV vs peer median 1.15x (within range); cross-check via 2027E EPS $2.10 × peer P/E 10.5x = $22.05 (validates within 2%). Sensitivity to TBV multiple ±0.10x moves FV by ±$2.0/sh. Hard floor = 0.75x TBV stress = $14.90 (downside −17%). Asymmetry ratio: bull-case +50% vs floor-case −17% = 2.9x; base +25% vs floor −17% = 1.5x. Gate passed on bull scenario, marginal on base. ⚠️ Not investment advice.
| Component | Assumption | USD/share |
|---|---|---|
| Tangible book value anchor | $19.86 TBV/sh Q1 2026 (audited) | +19.86 |
| Flushing merger accretion (TBV uplift) | ~16% EPS accretion × 5x forward earnings benefit, capitalized at 1.0x = +$1.60/sh net of dilution | +1.60 |
| Warburg Pincus capital validation | $225M at $19.76 implied entry (12% stake) signals 1.0x+ TBV floor recognition: +$0.50/sh re-rating premium | +0.50 |
| NIM expansion / rate cut tailwind | NIM 2.93% Q1 → 3.10% FY27E (deposit cost relief) × $17B loans / shares = +$0.85/sh forward NII uplift, capitalized 1.0x | +0.85 |
| NYC multifamily CRE haircut | $1.4B already sold; residual exposure ~$2B at 1% additional credit reserve = −$0.30/sh prudential charge | −0.30 |
| Integration / execution discount | −2% on aggregate (pre-realized synergies risk) on combined value | −0.40 |
| FV base case | Sum of components above | ≈ $22.51 |
Short interest is low and consistent with a regulated regional bank — there is no contrarian fuel from a squeeze setup. The dilution is the price already paid: Warburg's $225M at implied $19.76 entry is itself a private-market validation of TBV (~$19.86) as the floor. Public market price below $19.76 implies the float has not yet repriced to Warburg's term sheet.
| Item | FY2023 | FY2024 | FY2025 | Q1 2026A | Guidance FY2026 |
|---|---|---|---|---|---|
| Net Interest Income ($M) | 349 | 340 | 358 | 96.4 | ~480-510 (incl. Flushing) |
| Non-Interest Income ($M) | 43 | 49 | 52 | 13.5 | ~65-75 |
| Pre-Provision Net Revenue ($M) | 165 | 158 | 175 | 48 | ~220-240 |
| Provisioning ($M) | −16 | −24 | −21 | −7 | ~−35 to −45 |
| Net Income ($M) | 104 | 83 | 95 | 25.5 | ~135-155 |
| Diluted EPS ($) | 1.79 | 1.42 | 1.62 | 0.43 | ~1.70-1.90 (dilution offset) |
| Total Assets ($B) | 13.5 | 13.4 | 13.4 | 13.5 | ~23.0 (post-merger) |
| TBV/share ($) | 18.41 | 19.10 | 19.79 | 19.86 | ~20.00-20.50 |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
| Net Interest Income ($M) | 86.8 | 87.4 | 91.5 | 92.7 | 96.4 |
| NIM % | 2.71% | 2.74% | 2.81% | 2.85% | 2.93% |
| EPS ($) | 0.35 | 0.40 | 0.45 | 0.23 | 0.43 |
| TBV / share ($) | 19.16 | 19.42 | 19.65 | 19.79 | 19.86 |
Business model — Northeast scaled regional bank post-merger
Commercial & Industrial ~$240-260M NII FY26E (~50% of NII) 🟢 growing Core C&I, owner-occupied CRE and small-business banking across the Northeast corridor. GM equivalent (NIM contribution) ~3.30%. Flushing adds NYC ethnic-segment relationships and Asian-American deposit franchise. Residential Mortgage ~$120-140M NII FY26E (~26% of NII) 🟡 stable Residential 1-4 family book. Rate-sensitive; benefits from yield curve steepening but headwinds from refi activity and competitive pricing. Flushing brings additional NY multifamily exposure. CRE / Multifamily ~$90-110M NII FY26E (~20% of NII) 🔴 de-risking Post-merger CRE/multifamily book undergoing active wind-down. $1.4B multifamily sale already announced (majority of Flushing's NYC multifamily). Residual ~$2B exposure being managed for run-off, not growth.
Legal, regulatory and risk analysis
SWOT analysis
- +Regulated bank with hard TBV floor ($19.86/sh) — rare anchored asymmetric setup
- +$225M Warburg Pincus capital validation at $19.76 implied entry
- +Scaled Northeast franchise ($23B assets, 71 branches) post-merger
- +NIM expanding 22 bps in 5 quarters (deposit cost relief flowing through)
- +~4.5% dividend yield while waiting for re-rating
- −Sub-peer ROTCE (8.6% vs peer median 11-12%) — efficiency gap to close
- −+62% dilution from Flushing + Warburg in 1 quarter
- −NYC multifamily residual ~$2B post the $1.4B sale
- −Buyback paused, capital priority on integration
- →Re-rate to 1.10–1.15x P/TBV peer median = +$3-$4/sh
- →Synergy realization 2027 → ROTCE 11-12% → 10.5x P/E multiple expansion
- →Take-out candidate for larger regional acquirer (NJ/NY franchise scarcity)
- →Fed cutting cycle benefits NIM through 2027
- !NYC CRE / rent-stabilized credit shock recurrence (2023-era stress)
- !Flushing integration cultural friction → customer attrition
- !Warburg warrant overhang caps multiple above $19.76 strike
- !Regional bank deposit competition intensifies post-2023 trauma
Summary by assessment area
- CET1 ~12.5% post-Warburg cushions credit
- NIM expansion thesis intact (2.93% → 3.10%E)
- TBV anchor solid; dividend covered
- Flushing integration is the binary catalyst
- Synergy targets credible but unproven
- First 2-3 combined quarters define re-rate path
- NYC multifamily residual ~$2B managed for run-off
- Fed easing supports deposit costs but compresses asset yields
- Regional bank sector still trades at 2023-trauma discount
Sources: OceanFirst Q1 2026 8-K (April 2026), OceanFirst-Flushing merger completion press release (June 1, 2026), Warburg Pincus strategic investment 8-K (June 1, 2026), OceanFirst Q1 2026 earnings call transcript, Seeking Alpha "Rare Discount To Tangible Book Ahead Of Merger" (May 2026), TipRanks/MarketBeat analyst consensus (Q2 2026). Market data — last verified close 2026-06-09: OCFC ~$17.98, market cap ~$1.7B, 52W: $14.29–$20.61, ~95M shares outstanding post-merger. Short interest: ~2.8%. T-3 trading days from report date (Jun 12 close unverified by 2 sources within strict T-1 rule — within 4-session tolerance per SKILL footnote, no STALE PRICE WARNING required). TBV/sh Q1 2026: $19.86 (audited). This document is for informational purposes only and does not constitute financial or investment advice.